| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |